Note 16 - Subsequent Event

12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Subsequent Events [Text Block]

1

6

.

Subsequent Event

On

February 20, 2020,

we announced the signing of an amended and restated definitive agreement for the proposed merger of Progenics with Lantheus Holdings. The amended agreement reflects the renegotiation of certain of the terms of our original agreement for the proposed merger entered into on

October 1, 2019.

The combined company would be led by Lantheus Holdings’ Chief Executive Officer, Mary Anne Heino. Ms. Heino will be supported by Chief Financial Officer, Robert J. Marshall Jr., and Chief Operations Officer, John Bolla. The definitive agreement provides that, following the closing, Dr. Gérard Ber and Mr. Heinz Mäusli, currently members of Progenics’ Board of Directors (the “Board”), will be added as members of the Board of Directors of Lantheus Holdings. The transaction is expected to close early in the

second

quarter of

2020,

subject to approval by Lantheus Holdings and Progenics stockholders, regulatory approvals, and certain other customary closing conditions.